Ticker > Company >

Metropolis Health. share price

Metropolis Healthcare Ltd.

NSE: METROPOLIS BSE: 542650 SECTOR: Hospital & Healthcare Services  1.54 L   553   57

1964.65
-3.60 (-0.18%)
BSE: 28 Jul 04:01 PM

Price Summary

Today's High

₹ 1986

Today's Low

₹ 1944.65

52 Week High

₹ 2306.85

52 Week Low

₹ 1383.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

10178.35 Cr.

Enterprise Value

10152.83 Cr.

No. of Shares

5.18 Cr.

P/E

81.56

P/B

8.23

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  238.68

CASH

25.52 Cr.

DEBT

0 Cr.

Promoter Holding

48.89 %

EPS (TTM)

₹  24.09

Sales Growth

10.25%

ROE

11.04 %

ROCE

16.26%

Profit Growth

7.69 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.25%
3 Year1.69%
5 Year12.83%

Profit Growth

1 Year7.69%
3 Year-14.48%
5 Year2.18%

ROE%

1 Year11.04%
3 Year12.91%
5 Year19.39%

ROCE %

1 Year16.26%
3 Year18.05%
5 Year26.16%

Debt/Equity

0

Price to Cash Flow

37.01

Interest Cover Ratio

8.0483

CFO/PAT (5 Yr. Avg.)

1.65659399115355

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 48.89 1.18
Mar 2025 48.89 1.18
Dec 2024 49.40 1.18
Sep 2024 49.43 1.18
Jun 2024 49.62 1.18
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 8.0483.
  • The Company has been maintaining an effective average operating margins of 25.8753830392597% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -103.2552 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.65659399115355.

 Limitations

  • The company has shown a poor profit growth of -14.4812824223144% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.68643928349106% for the Past 3 years.
  • The company is trading at a high PE of 81.56.
  • The company is trading at a high EV/EBITDA of 35.0218.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 292.27 286.14 321.57 296.88 311.95
Total Expenditure 218.35 217.87 239.55 231.78 259.21
Operating Profit 73.92 68.27 82.02 65.1 52.74
Other Income 2.02 2.83 3.59 3.03 7.6
Interest 5.65 4.61 4.73 4.49 4.43
Depreciation 25.24 24.76 26.01 26.85 27.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 45.06 41.72 54.87 36.8 28.63
Tax 13.27 10.44 12.6 9.4 4.78
Profit After Tax 31.78 31.28 42.26 27.41 23.85
Adjusted EPS (Rs) 6.2 6.11 8.25 5.35 4.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 961.39 1157.01 1066.04 1103.43 1216.54
Total Expenditure 676.52 832.71 794.56 840.03 944.27
Operating Profit 284.87 324.3 271.48 263.39 272.27
Other Income 12.31 16.15 23.72 12 17.63
Interest 11.26 24.54 31.29 27.25 22.99
Depreciation 43.78 60.26 84.96 90.73 104.89
Exceptional Items 0 15.9 0 0 0
Profit Before Tax 242.13 271.55 178.95 157.41 162.02
Tax 59.48 72.01 40 41.52 37.23
Net Profit 182.65 199.53 138.95 115.89 124.8
Adjusted EPS (Rs.) 35.73 38.99 27.13 22.62 24.09

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 10.22 10.23 10.24 10.25 10.36
Total Reserves 654.59 828.97 925.77 1020.94 1234.09
Borrowings 0 158.68 30.77 0 0
Other N/C liabilities 113.78 333.26 386.48 226.35 405.09
Current liabilities 222.04 347.89 290.5 263.13 435.62
Total Liabilities 1000.63 1679.03 1643.78 1520.67 2085.16
Assets
Net Block 307.09 1004.73 1065.77 1120.09 1129.11
Capital WIP 0 0 0 0 0
Intangible WIP 0 5.78 19.51 0 0
Investments 3.54 36.65 36.65 36.65 255.55
Loans & Advances 67.29 201.44 217.97 59.86 253.26
Other N/C Assets 1.64 16.28 1.21 2.87 0.59
Current Assets 621.06 414.15 302.67 301.2 446.66
Total Assets 1000.63 1679.03 1643.78 1520.67 2085.16
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 242.13 271.55 178.95 157.41 162.02
Adjustment 71.33 54.34 96.11 116.52 126.38
Changes in Assets & Liabilities -22.16 -5.67 6.72 22.34 20.39
Tax Paid -55.06 -76.17 -44.04 -27.26 -33.79
Operating Cash Flow 236.23 244.04 237.74 269.01 275.01
Investing Cash Flow 59.42 -736.21 46.72 -81.51 -196.41
Financing Cash Flow -31.27 171.97 -287.87 -183 -84.5
Net Cash Flow 264.38 -320.19 -3.4 4.5 -5.9

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 49.62 49.43 49.40 48.89 48.89
ameera sushil shah 0.35 0.35 0.35 0.35 0.35
duru shah family trust (d... - - - - 11.06
metz advisory llp 30.63 30.62 30.61 30.29 30.29
sushil shah family trust ... - - - - 7.19
duru shah family trust 9.69 9.69 9.68 11.06 -
sushil kanubhai shah 2.45 2.28 2.28 2.25 -
sushil shah family trust 4.99 4.99 4.99 4.94 -
duru sushil shah 1.49 1.49 1.49 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 50.38 50.57 50.60 51.11 51.11
aditya birla sun life tru... - 1.17 1.12 1.54 1.55
canara robeco mutual fund... - 1.21 1.21 1.13 1.13
core diagnostics (mauriti... - - - 1.00 1.00
franklin india smaller co... 3.29 3.04 2.33 2.09 3.32
hdfc mutual fund - hdfc f... - - - - 9.67
icici prudential pharma h... - - - - 1.08
kotak small cap fund - - - 2.92 3.29
llp 0.01 0.01 0.02 0.15 0.02
nippon life india trustee... 2.29 2.29 2.73 2.28 2.28
sundaram mutual fund a/c ... - - 1.13 1.50 1.43
tata business cycle fund - - - - 1.70
uti value fund - - - 3.57 3.50
hdfc mutual fund - hdfc f... 8.99 9.44 9.71 9.64 -
j p morgan funds 1.92 1.90 1.71 1.59 -
jpmorgan indian investmen... 1.39 1.21 1.20 1.08 -
sbi life insurance co. lt... 2.16 2.21 2.14 2.11 -
uti flexi cap fund - - 4.60 - -
caisse de depot et placem... 1.44 1.39 - - -
fssa indian subcontinent ... 1.23 1.22 - - -
the scottish oriental sma... 1.19 1.15 - - -
uti large cap fund 5.17 5.02 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CARE
Credit CARE
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research NuvamaWealth
Research Nuvama Wealth
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research HDFC Securities
Research Edelweiss
Research Prabhudas Lilladhar
Research Geojit BNP Paribas

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY23
Concall Q4FY22
Concall Q4FY21
Concall Q4FY19
Concall Q3FY22
Concall Q3FY21
Concall Q2FY25
Concall Q2FY22
Concall Q2FY21
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY19
Presentation Q3FY24
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY25
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21

Company News

Metropolis Health. Stock Price Analysis and Quick Research Report. Is Metropolis Health. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Metropolis Health. and its performance over the period of time. Metropolis Health. stock price today is Rs 1965.4.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Metropolis Health. cash from the operating activity was Rs 275.0071 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Metropolis Health. has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Metropolis Health. , the EPS growth was 6.493 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Metropolis Health. has OPM of 22.3804994973462 % which is a good sign for profitability.
     
  • ROE: Metropolis Health. have a average ROE of 11.044 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Metropolis Health. is Rs 1965.4. One can use valuation calculators of ticker to know if Metropolis Health. share price is undervalued or overvalued.
Last Updated on:
Brief about Metropolis Health.
X